Otsuka T, Eaves C J, Humphries R K, Hogge D E, Eaves A C
Terry Fox Laboratory, Vancouver, British Columbia, Canada.
Leukemia. 1991 Oct;5(10):861-8.
Previous studies have revealed a consistent defect in the cycling behavior of primitive neoplastic progenitor cells in patients with Philadelphia chromosome (Ph1)-positive chronic myeloid leukemia (CML). This is manifested both in vivo and in long-term cultures of CML cells as an increased rate of turnover amongst Ph1-positive progenitor cell types whose counterparts in normal individuals are mainly quiescent. To determine whether this deregulated proliferative activity of primitive Ph1-positive cells might be explained by a perturbation in the production of growth factors that regulate the turnover of primitive normal cells, the possibility of either autocrine or paracrine mechanisms of Ph1-positive cell stimulation was investigated. Northern blot analysis of total cellular RNA extracted from various CML blood cell populations showed no evidence of increased expression of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage-CSF (GM-CSF), interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-3, IL-6, or tumor necrosis factor-alpha (TNF-alpha) compared with analogous normal peripheral blood cell populations in which transcripts for most of these growth factors are not detectable. A similar analysis of RNA extracted from the adherent layer of 4-week-old long-term cultures established from CML marrow (in which the Ph1-positive cells typically disappear) or from CML blood seeded onto normal marrow adherent layers (in which Ph1-positive cells typically persist) also revealed no difference in growth factor production compared with analogous cultures established with exclusively normal cells. For some of the growth factors studied, the assessment of bioactivity detectable in the medium confirmed the RNA data. There was also no evidence of a decreased production of putative inhibitors of primitive hematopoietic cells, i.e. transforming growth factor-beta and macrophage inflammatory protein-1 alpha by CML versus normal cells or cultures. These results do not support the existence of BCR-ABL induced autocrine or paracrine mechanisms in CML and suggest that constitutive activation of events normally dependent on growth factor receptor stimulation is more likely to underlie the lack of proliferation control exhibited by primitive Ph1-positive cells.
以往研究显示,费城染色体(Ph1)阳性慢性髓性白血病(CML)患者的原始肿瘤祖细胞在循环行为方面存在持续缺陷。这在CML细胞的体内和长期培养中均有体现,即Ph1阳性祖细胞类型的更新率增加,而正常个体中的对应祖细胞主要处于静止状态。为了确定原始Ph1阳性细胞这种失调的增殖活性是否可能由调节原始正常细胞更新的生长因子产生紊乱所解释,研究了Ph1阳性细胞刺激的自分泌或旁分泌机制的可能性。对从各种CML血细胞群体中提取的总细胞RNA进行Northern印迹分析,结果显示,与大多数这些生长因子转录本无法检测到的正常外周血细胞类似群体相比,粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素-1α(IL-1α)、IL-1β、IL-3、IL-6或肿瘤坏死因子-α(TNF-α)的表达没有增加。对从CML骨髓建立的4周龄长期培养物的贴壁层(其中Ph1阳性细胞通常消失)或接种到正常骨髓贴壁层上的CML血液(其中Ph1阳性细胞通常持续存在)中提取的RNA进行类似分析,与仅用正常细胞建立的类似培养物相比,生长因子产生也没有差异。对于一些研究的生长因子,对培养基中可检测到的生物活性的评估证实了RNA数据。也没有证据表明CML细胞与正常细胞或培养物相比,原始造血细胞的假定抑制剂即转化生长因子-β和巨噬细胞炎性蛋白-1α的产生减少。这些结果不支持CML中存在BCR-ABL诱导的自分泌或旁分泌机制,并表明通常依赖生长因子受体刺激的事件的组成性激活更可能是原始Ph1阳性细胞缺乏增殖控制的基础。